Larvol Delta - A-new-era-in-the-treatment-of-metabolic-dysfunctionassociated-steatotic-liver-disease-MASLD-clinical-breakthroughs-and-challenges

Kerendia (finerenone) - Bayer

clazakizumab (CSL300) - CSL Behring, Eli Lilly

ziltivekimab (COR-001) - Novo Nordisk

http://www.ncbi.nlm.nih.gov/pubmed/42739556

Aris Tsalouchos; Pietro Claudio Dattolo

Sep 16, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next